HeartFlow, Inc.

HeartFlow, Inc. is a medical technology company focused on non‑invasive diagnosis and management of coronary artery disease. Its platform applies artificial intelligence and computational fluid dynamics to coronary CT angiography to generate personalized 3D models of the heart, delivering insights on blood flow, lesion severity, and plaque burden from a single scan. By augmenting standard imaging with physiology and plaque characterization, HeartFlow aims to help clinicians triage patients more efficiently, reduce unnecessary invasive procedures, and guide treatment planning across the guideline-directed CCTA pathway. The company’s portfolio includes capabilities such as FFRCT analysis and plaque analysis, supported by extensive clinical literature and adoption across healthcare institutions globally. Founded in 2007 and headquartered in Mountain View, California, HeartFlow serves cardiology practices, hospitals, and health systems seeking precision tools for CAD detection and longitudinal management. Its work positions the firm within diagnostics and research at the intersection of software, imaging, and cardiovascular care, reflecting a broader shift toward data-driven, patient-specific decision support in healthcare.